Dynavax Technologies Stock Analysis
| DVAX Stock | USD 12.91 0.25 1.97% |
Dynavax Technologies is undervalued with Real Value of 15.7 and Target Price of 24.5. The main objective of Dynavax Technologies stock analysis is to determine its intrinsic value, which is an estimate of what Dynavax Technologies is worth, separate from its market price. There are two main types of Dynavax Technologies' stock analysis: fundamental analysis and technical analysis.
The Dynavax Technologies stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Dynavax Technologies is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Dynavax Stock trading window is adjusted to America/New York timezone.
Dynavax |
Dynavax Stock Analysis Notes
About 100.0% of the company shares are held by institutions such as insurance companies. The book value of Dynavax Technologies was currently reported as 5.19. The company had not issued any dividends in recent years. Dynavax Technologies had 1:10 split on the 10th of November 2014. Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California. Dynavax Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 311 people. To learn more about Dynavax Technologies call the company at 510 848 5100 or check out https://www.dynavax.com.Dynavax Technologies Investment Alerts
| The company reported the previous year's revenue of 232.28 M. Net Loss for the year was (6.39 M) with profit before overhead, payroll, taxes, and interest of 448.22 M. | |
| Dynavax Technologies has a frail financial position based on the latest SEC disclosures | |
| Over 100.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from zacks.com: Does Dynavax Technologies Have the Potential to Rally 93.52 percent as Wall Street Analysts Expect |
Dynavax Technologies Upcoming and Recent Events
Earnings reports are used by Dynavax Technologies to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Dynavax Largest EPS Surprises
Earnings surprises can significantly impact Dynavax Technologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-02-22 | 2023-12-31 | -0.01 | 0.0016 | 0.0116 | 116 | ||
2024-08-06 | 2024-06-30 | 0.06 | 0.08 | 0.02 | 33 | ||
2021-05-06 | 2021-03-31 | -0.02 | 0.01 | 0.03 | 150 |
Dynavax Technologies Environmental, Social, and Governance (ESG) Scores
Dynavax Technologies' ESG score is a quantitative measure that evaluates Dynavax Technologies' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Dynavax Technologies' operations that may have significant financial implications and affect Dynavax Technologies' stock price as well as guide investors towards more socially responsible investments.
Dynavax Technologies Thematic Classifications
In addition to having Dynavax Technologies stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Pharmaceutical ProductsUSA Equities from Pharmaceutical Products industry as classified by Fama & French |
Dynavax Stock Institutional Investors
| Shares | Great Point Partners Llc | 2024-06-30 | 2.4 M | Blair William & Co | 2024-06-30 | 2.4 M | Renaissance Technologies Corp | 2024-09-30 | 2.3 M | Tang Capital Management Llc | 2024-09-30 | 1.9 M | Millennium Management Llc | 2024-06-30 | 1.6 M | D. E. Shaw & Co Lp | 2024-09-30 | 1.4 M | Mizuho Markets Americas Llc | 2024-09-30 | 1.4 M | Fisher Asset Management, Llc | 2024-09-30 | 1.4 M | Northern Trust Corp | 2024-09-30 | 1.3 M | Blackrock Inc | 2024-06-30 | 21.9 M | Deep Track Capital, Lp | 2024-09-30 | 12.5 M |
Dynavax Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.7 B.Dynavax Profitablity
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | (0.04) | (0.04) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
Management Efficiency
Return On Tangible Assets is likely to drop to -0.0067 in 2024. Return On Capital Employed is likely to drop to -0.04 in 2024. At this time, Dynavax Technologies' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 21.4 M in 2024, whereas Other Assets are likely to drop slightly above 3 M in 2024. Dynavax Technologies' management efficiency ratios could be used to measure how well Dynavax Technologies manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.83 | 5.07 | |
| Tangible Book Value Per Share | 4.82 | 5.06 | |
| Enterprise Value Over EBITDA | 197.22 | 207.08 | |
| Price Book Value Ratio | 2.89 | 4.48 | |
| Enterprise Value Multiple | 197.22 | 207.08 | |
| Price Fair Value | 2.89 | 4.48 | |
| Enterprise Value | 356.6 M | 317 M |
Evaluating the management effectiveness of Dynavax Technologies allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Dynavax Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Operating Margin 0.1524 | Profit Margin 0.0785 | Beta 1.342 | Return On Assets (0) | Return On Equity 0.0318 |
Technical Drivers
As of the 29th of November, Dynavax Technologies shows the Mean Deviation of 1.74, downside deviation of 2.37, and Coefficient Of Variation of 1002.84. Dynavax Technologies technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Dynavax Technologies Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Dynavax Technologies middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Dynavax Technologies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Dynavax Technologies Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Dynavax Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on Dynavax Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Dynavax Technologies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Dynavax Technologies Outstanding Bonds
Dynavax Technologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Dynavax Technologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Dynavax bonds can be classified according to their maturity, which is the date when Dynavax Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Dynavax Technologies Predictive Daily Indicators
Dynavax Technologies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Dynavax Technologies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Dynavax Technologies Corporate Filings
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 29th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 24th of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
13A | 18th of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 16th of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
F3 | 16th of September 2024 The schedule filed by any person or group who acquires beneficial ownership of more than 5% of a voting class of a company's equity securities registered under Section 12 of the Act | ViewVerify |
Dynavax Technologies Forecast Models
Dynavax Technologies' time-series forecasting models are one of many Dynavax Technologies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Dynavax Technologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Dynavax Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Dynavax Technologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Dynavax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Dynavax Technologies. By using and applying Dynavax Stock analysis, traders can create a robust methodology for identifying Dynavax entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.02) | (0.02) | |
| Operating Profit Margin | (0.16) | (0.17) | |
| Net Loss | (0.03) | (0.03) | |
| Gross Profit Margin | 0.78 | 0.82 |
Current Dynavax Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Dynavax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Dynavax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 24.5 | Strong Buy | 5 | Odds |
Most Dynavax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Dynavax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Dynavax Technologies, talking to its executives and customers, or listening to Dynavax conference calls.
Dynavax Stock Analysis Indicators
Dynavax Technologies stock analysis indicators help investors evaluate how Dynavax Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Dynavax Technologies shares will generate the highest return on investment. By understating and applying Dynavax Technologies stock analysis, traders can identify Dynavax Technologies position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 202.2 M | |
| Total Stockholder Equity | 622.1 M | |
| Capital Lease Obligations | 34.2 M | |
| Property Plant And Equipment Net | 61.6 M | |
| Cash And Short Term Investments | 742.3 M | |
| Cash | 150.3 M | |
| 50 Day M A | 11.5918 | |
| Net Interest Income | 20 M | |
| Total Current Liabilities | 62.2 M | |
| Forward Price Earnings | 49.7512 | |
| Investments | -166.7 M | |
| Interest Expense | 6.8 M | |
| Stock Based Compensation | 42.6 M | |
| Long Term Debt | 222.7 M | |
| Common Stock Shares Outstanding | 128.7 M | |
| Tax Provision | 1.5 M | |
| Quarterly Earnings Growth Y O Y | 0.208 | |
| Free Cash Flow | 96.5 M | |
| Other Current Assets | 19 M | |
| Accounts Payable | 5.2 M | |
| Net Debt | 106.6 M | |
| Other Operating Expenses | 269.3 M | |
| Non Current Assets Total | 138 M | |
| Liabilities And Stockholders Equity | 997.1 M | |
| Non Currrent Assets Other | 74.3 M |
Additional Tools for Dynavax Stock Analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.